Jiangsu Bioperfectus Technologies Co (SHSE:688399) ROCE % : 0.23% (As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Jiangsu Bioperfectus Technologies Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Jiangsu Bioperfectus Technologies Co's annualized ROCE % for the quarter that ended in Sep. 2024 was 0.23%.

Jiangsu Bioperfectus Technologies Co ROCE % Historical Data

The historical data trend for Jiangsu Bioperfectus Technologies Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Bioperfectus Technologies Co ROCE % Chart

Jiangsu Bioperfectus Technologies Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

13.00

68.07

63.34

64.95

-9.83

Jiangsu Bioperfectus Technologies Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															-9.81	-22.94	4.72	-0.64	0.23

Jiangsu Bioperfectus Technologies Co ROCE % Calculation

Jiangsu Bioperfectus Technologies Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-368.731	/	( ( (4891 - 932.598)	+	(3906.413 - 363.869) )	/ 2 )
	=	-368.731	/	( (3958.402	+	3542.544)	/ 2 )
	=	-368.731	/	3750.473
	=	-9.83 %

Jiangsu Bioperfectus Technologies Co's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	7.9	/	( ( (4004.213 - 444.331)	+	(3856.867 - 442.631) )	/ 2 )
	=	7.9	/	( ( 3559.882	+	3414.236 )	/ 2 )
	=	7.9	/	3487.059
	=	0.23 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Jiangsu Bioperfectus Technologies Co (SHSE:688399) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Jiangsu Bioperfectus Technologies Co ROCE % Related Terms

Thank you for viewing the detailed overview of Jiangsu Bioperfectus Technologies Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Jiangsu Bioperfectus Technologies Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jiangsu Bioperfectus Technologies Co Ltd (SHSE:688399) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

3rd floor, Block G19, No.1 Yaocheng Avenue, Jiangsu, Taizhou, CHN

Website

http://www.s-sbio.com

Jiangsu Bioperfectus Technologies Co Ltd is engaged in product development, production and sales of disease prevention and control, female genital micro-ecological testing and tumor screening. Its products portfolio includes Fever respiratory pathogen detection series, Fever with a rash pathogen test series, Fever with bleeding pathogen test series, Foodborne diseases and diarrheal pathogen detection and Other types of pathogen detection series.

Executives

Jin Jing

Supervisors

Jiangsu Bioperfectus Technologies Co Headlines

No Headlines